Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of “Moderate Buy” from Brokerages

Certara, Inc. (NASDAQ:CERT) has been assigned an average rating of “Moderate Buy” from the eight research firms that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $15.83.

Several brokerages recently weighed in on CERT. William Blair reissued a “market perform” rating on shares of Certara in a research note on Thursday, February 27th. Barclays upped their price objective on shares of Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Stephens reaffirmed an “overweight” rating and issued a $17.00 target price on shares of Certara in a research note on Thursday, February 27th. Finally, TD Cowen assumed coverage on Certara in a report on Thursday, February 27th. They set a “buy” rating and a $16.00 price objective on the stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Blue Trust Inc. raised its position in shares of Certara by 20.9% during the 4th quarter. Blue Trust Inc. now owns 4,747 shares of the company’s stock valued at $56,000 after acquiring an additional 822 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of Certara by 3.6% in the 4th quarter. The Manufacturers Life Insurance Company now owns 23,720 shares of the company’s stock worth $253,000 after buying an additional 823 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Certara by 48.4% in the 4th quarter. Wells Fargo & Company MN now owns 3,208 shares of the company’s stock valued at $34,000 after buying an additional 1,047 shares during the period. Nicolet Advisory Services LLC grew its position in shares of Certara by 6.6% during the 3rd quarter. Nicolet Advisory Services LLC now owns 24,831 shares of the company’s stock valued at $273,000 after buying an additional 1,531 shares during the last quarter. Finally, KBC Group NV raised its stake in Certara by 48.2% during the third quarter. KBC Group NV now owns 4,873 shares of the company’s stock worth $57,000 after acquiring an additional 1,584 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

Certara Stock Performance

Certara stock opened at $10.73 on Monday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. Certara has a fifty-two week low of $9.41 and a fifty-two week high of $19.18. The stock has a fifty day moving average of $12.55 and a two-hundred day moving average of $11.49. The company has a market capitalization of $1.73 billion, a price-to-earnings ratio of -53.65, a PEG ratio of 9.29 and a beta of 1.60.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.